Four research teams at Columbia University have been awarded the inaugural Edward P. Evans Center for Myelodysplastic Syndromes (MDS) Pilot Awards and Fellowships.
The center, established by the Herbert Irving Comprehensive Cancer Center (HICCC) in December 2021, is dedicated to the study and treatment of MDS, a malignant disease that attacks bone marrow stem cells. Each year, more than 40,000 individuals are diagnosed with MDS, and roughly one-third will develop acute myeloid leukemia (AML), a severe and rapidly progressing form of blood cancer.
To support their research, each team will receive a one-year $100,000 grant for the Edward P. Evans Center Pilot Awards and a two-year $60,000/year grant for the fellowships. The two pilot projects are being led by principal investigators Pawel Muranski, MD, assistant professor of medicine and of pathology and cell biology at Columbia University Vagelos College of Physicians and Surgeons (VP&S); Amer Assal, MD, assistant professor of medicine at VP&S; and Raul Rabadan, PhD, professor of systems biology and of biomedical informatics at VP&S. The two fellowships have been awarded to Rossella Labella, PhD, postdoctoral research scientist in the Department of Physiology and Cellular Biophysics(link is external and opens in a new window), and Junsong Zhou, PhD, associate research scientist in the Department of Rehabilitation and Regenerative Medicine.
Read full article on HICCC Newsroom.